Jupiter Life Line Hospitals Ltd. · NSE:JLHL
Jupiter Life Line Hospitals — Q1 FY27 Earnings Presentation
10 slides from Jupiter Life Line Hospitals's earnings presentation, Jul 31, 2026
Slide 1: Cover letter to National Stock Exchange and BSE
July 31, 2026 To, To, National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, BKC P.J. Towers, Bandra-Kurla Complex, 25th Floor, Dalal Street, Fort Bandra (East), Mumbai-400 051 Mumbai 400 001 Symbol: JLHL Code: 543980 Subject: Investor Presentation for the quarter ended June 30, 2026. Ref
Slide 2: Investor Presentation July 2026
CARE THAT Trusted. Tested. MOVES FORWARD, Transforming. EVERY YEAR. Investor Presentation July 2026 Investor Presentation July 2026
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Jupiter Life Line Hospitals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe
Slide 4: Management Commentary
Management Commentary Patient First “Our Dombivli hospital completed its first full quarter of operations, occupancy has been increasing steadily, supported by increasing patient footfall, expansion of clinical services and growing patient acceptance. The EBITDA loss from Dombivli of 9.5 crore in th
Slide 5: Q1FY27 Performance Highlights
Q1FY27 Performance Highlights Rs in Cr Total Income EBITDA PBT PAT 411.0 78.4 79.3 61.7 43.9 353.0 37.5 50.6 320.0 274.8 63.1 72.6 15.1 18.4 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 IPD OPD Others • EBITDA impacted by initial ramp-up loss of Rs 9.5 cr in Dombivli and higher marketing
Slide 6: Q1FY27 Operating Metrics
Q1FY27 Operating Metrics Operational Bed Capacity(1) Average Occupancy Rate(2) IPD & OPD Volumes (‘000)(3) Excluding Census Beds Non - Census Beds 61.7% Dombivli 60.1% 59.6% Hospital 291.5 1,259 259.1 14.2 1,061 IPD 13.3 1,063 929 OPD 245.8 277.3 132 196 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 ARP
Slide 7: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Profit and Loss (in Rs. Crs) Q1FY27 Q1FY26 YoY Q4FY26 QoQ FY26 Revenue from Operations 392.6 337.9 16.2% 371.7 5.6% 1,435.6 Other Income - Operational 18.4 15.0 16.1 64.2 Total Income 411.0 352.9 16.4% 387.8 6.0% 1,499.8 Cost of Goods Sold 80.0 70.7 73.7 287.3 Gr
Slide 8: Next-Phase of Growth: Scaling Bed Capacity from 1,700 to 2,900
Next-Phase of Growth: Scaling Bed Capacity from 1,700 to 2,900 Hospitals Bed Capacity Capex/Bed Remarks (Excl. Land) (Rs in cr) Recently Commissioned Dombivli 500 1.0 Phase-wise commissioning underway, with ~200 beds operational and fit-outs completed for an additional 100 beds Greenfield Pune II 50
Slide 9: Funding Philosophy
Funding Philosophy Internal accruals Cash on hand Leverage Cash flow to EBITDA conversion averaging~75–80% over the last five Cash & Cash Equivalent, including Targeted Debt/EBITDA is expected to years is expected to support a significant Investments of Rs 537.7 crs remain below 3x portion of the pl
Slide 10: Thank You
http://www.sgapl.net/images/sgapl_logo.jpg Jupiter JupiterLife LifeLine LineHospitals HospitalsLimited Limited Strategic Growth Advisors Pvt. Ltd. CIN: CIN:L85100MH2002PLC137908 L85100MH2002PLC137908 CIN: U74140MH2010PTC204285 Mandar Chavan / Rahul Agarwal investor.relations@jupiterhospital.com inve
Jupiter Life Line Hospitals — Q1 FY27 Earnings Presentation on 6ix